Live feed08:30:00·21hPRReleasevia QuantisnowQuoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton SyndromeByQuantisnow·Wall Street's wire, on your screen.QNRX· Quoin Pharmaceuticals Ltd.Health Care
